Events > Barcelona Biotech Breakfast: Applying AI in Drug Discovery and Drug Development



row-start col-md-7 #top-section top-section #about-section no-pad-bottom-section

About the event

Machine learning and other technologies are expected to make the hunt for new pharmaceuticals quicker, cheaper and more effective. In today's digital economy, digitisation has become a vital way to build competitive differentiation in an encreasingly competitive market. Artificial intelligence has a projected market value in drug discovery expected to reach $4 billion by 2024.

This DIT Barcelona Biotech Breakfast will take place at the Parc Cientific de Barcelona on Wednesday 19th June 2019. The event will include masterclasses in an open panel discussion format with leading British and Catalan speakers sharing their knowledge of artificial intelligence in drug discovery and development. There will be networking opportunities where you can meet the experts and ask any questions. The DIT Barcelona team are also happy to organise one to one meetings for any attendees with the UK companies and organisations.

Full programme of speakers to be published and the events page and sent to registered attendees to follow shortly.

Attendance to the event is free but seats are limited, so register now to reserve your place!

row-start col-xs-12 no-pad-bottom-section #agenda-section


col-xs-12 agenda-section row-end top-80
Wednesday, 19 June 2019
08:30 - 09:00Registration
09:00 - 09:10Opening speeches
Maria Terrades, General Director, Parc Cientific de Barcelona
Chris Doherty, Managing Director, Alderley Park
09:10 - 10:25Panel discussion 1 - Pre-clinical applications of AI in drug discovery and development
Moderator: Dr Edward Pyzer-Knapp, Dr and Visiting Professor of Industrially Applied AI, University of Liverpool, IBM
Enric Herrero, CTO, Pharmacelera
Jascha Blobel, CEO, Molomics
Anthony Bashall, Director, Zenzium
Satnam Surae, Chief Product Officer, Aigenpulse
David Bunton, CEO, Reprocell
10:25 - 11:45Panel discussion 2 - Clinical applications of AI in drug discovery and development
Moderator: Cristian Martí, Founder, Methinks
John Overington, Professor, Medicines Discovery Catapult
Javier de la Oca, CEO, IOMED
Professor Manuel Salto-Tellez, Lead of Queen's Medicine Centre of Excellence and Professor of Molecular Pathology , Queen's Univeristy Belfast
Euan Cameron, CEO and Founder, Cohesion Medical
Raja Sharif, CEO, Farmatrust
John McCrae, Chief Technology Officer , North West EHealth (NWEH)
11:45Closing remarks UK Department for International Trade (DIT) followed by Networking COFFEE and refreshments
12:30End of session
row-start col-xs-12 #speakers-section

In partnership with:  

row-start col-md-7 #venue-section



Parc Cientific de Barcelona

Baldiri i Reixac 10-12

08028 Barcelona






row-start col-xs-12 colour-section

To request further information or an individual meeting with a specific company,please contact us on:

Jessica Griffiths, Senior Trade and Investment Adviser


Tel: +34 93 366 6204

Aurora Ortega, Trade & Investment Assistant


Tel. +34 93 366 6207



row-mid col-md-7 colour-section



col-xs-12 sponsors-section row-mid
row-start col-xs-12 col-md-8 colour-section narrow-section
row-end col-xs-12 col-md-4